SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-025486
Filing Date
2020-12-16
Accepted
2020-12-16 17:14:51
Documents
15
Period of Report
2020-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vcyt20201216_8k.htm   iXBRL 8-K 27544
2 EXHIBIT 99.1 VERACYTE PRESS RELEASE DATED DECEMBER 16, 2020 ex_217949.htm EX-99.1 15070
7 ex_217949img001.jpg GRAPHIC 3221
  Complete submission text file 0001437749-20-025486.txt   184699

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20201216.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcyt-20201216_def.xml EX-101.DEF 11587
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20201216_lab.xml EX-101.LAB 15467
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20201216_pre.xml EX-101.PRE 11741
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt20201216_8k_htm.xml XML 2570
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 201393281
SIC: 8071 Services-Medical Laboratories